Condition
Scorpion Stings
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Unknown1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06615440Not Yet RecruitingPrimary
Management and Outcome of Scorpion Sting in Children
NCT05125796Not ApplicableCompletedPrimary
Analgesic Use for Pain Relief in Scorpion Sting
NCT04571411UnknownPrimary
Severity of Scorpion Sting in Relation to Hematological Parameters
NCT03622125CompletedPrimary
Decrease in Temperature as a Pagtonomic Sign by Scorpion Sting
NCT03943199Not ApplicableCompletedPrimary
Comparison of Lysine Clonixinate, Ketorolac and Metamizole Sodium in Scorpion Stings
Showing all 5 trials